  Multiple sclerosis (MS) is a progressive inflammatory and neurodegenerative
disease of the central nervous system affecting over 2.5 million people
globally. In-clinic six-minute walk test (6MWT) is a widely used objective
measure to evaluate the progression of MS. Yet, it has limitations such as the
need for a clinical visit and a proper walkway. The widespread use of wearable
devices capable of depicting patients activity profiles has the potential to
assess the level of MS-induced disability in free-living conditions. In this
work, we extracted 96 activity features in different temporal granularities
(from minute-level to day-level) and explored their utility in estimating 6MWT
scores in a European (Italy, Spain, and Denmark) MS cohort of 337 participants
over an average of 10-month duration. We combined these features with
participant demographics using three regression models including elastic net,
gradient boosted trees and random forest. In addition, we quantified the
individual feature contribution using feature importance in these regression
models, linear mixed-effects models, generalized estimating equations, and
correlation-based feature selection (CFS). The results showed promising
estimation performance with R2 of 0.30, which was derived using random forest
after CFS. This model was able to distinguish the participants with low
disability from those with high disability. Furthermore, we observed that the
minute-level (no longer than 8 minutes) step count, particularly those
capturing the upper end of the step count distribution, had a stronger
association with 6MWT. The use of a walking aid was indicative of ambulatory
function measured through 6MWT. This study provides a basis for future
investigation into the clinical relevance and utility of wearables in assessing
MS progression in free-living conditions.
